(Total Views: 461)
Posted On: 01/15/2021 9:44:46 PM
Post# of 72446
The IPIX 22 July PR said that IPIX had granted licensing rights to Fox Chase Chemical Diversity Ctr for antifungal technology for the following:
Under the amended terms, and in exchange for a six (6) percent fee tied to all potential future proceeds—including upfront payments, milestone payments and royalties—the Company is granting FCCDC all discovery, intellectual property and commercialization rights related to its share of their joint antifungal drug program.
I took from this PR that we didn't give back the rights to the antifungal portion of Brilacidin to U of Penn.
Would appreciate clarification on this subject. Thanks.
Under the amended terms, and in exchange for a six (6) percent fee tied to all potential future proceeds—including upfront payments, milestone payments and royalties—the Company is granting FCCDC all discovery, intellectual property and commercialization rights related to its share of their joint antifungal drug program.
I took from this PR that we didn't give back the rights to the antifungal portion of Brilacidin to U of Penn.
Would appreciate clarification on this subject. Thanks.
(0)
(0)
